English articles
- A Record AI Drug-Discovery Financing: Why a Google-Backed Company Raised US$2.1 Billion
- HIV Drugs Are Still Highly Profitable: What Gilead's Earnings Reveal
- Where Pfizer Misjudged the Vepdegestrant Strategy
- Daiichi Sankyo's Most Expensive Lesson: How an ADC Capacity Bet Can Backfire After a Blockbuster
- Johnson & Johnson Cuts Two Autologous Lymphoma CAR-T Programs
- The FDA Commissioner's Exit: Why the World's Most Important Drug Referee Is Becoming Less Predictable
- A Complete Map of the New Antidepressant Drug Pipeline
- How PharmaEssentia's Besremi Opens a Larger Valuation Imagination
- Could Neuroinflammation Bring CNS Drug Development Back?
- The Autoimmune Twins That Could Save Johnson & Johnson
- Could DAC Become the Next Breakout Format in Targeted Therapy?
- Trump Delays the Policy Signal: Did Weight-Loss Drugs Cut Prices for Nothing?
- Clinical-Trial Fraud and an FDA Withdrawal Storm
- Weight-Loss Drugs Are Still Too Strong: Lilly's Mounjaro Keeps Printing Money
- The Shadow Behind the Next Century-Defining Drug
- Free Taipei Workshop: Using an NPV Framework to Identify Biotech Re-Rating Points
- What Makes a Pipeline Attractive to Big Pharma?
- The Hair-Growth Drug That Jumped 47%: Why It Could Rewrite Three Decades of Hair-Loss Treatment
- In Vivo CAR-T: Bubble or the Most Expensive Ticket to Next-Generation Cell Therapy?
- The Ambition of an Indian Pharma Giant: Acquiring a US Drugmaker
- Is the 20-Year Amyloid Hypothesis in Alzheimer's Disease Starting to Collapse?
- Amazon Enters AI Drug Discovery and Challenges Nvidia's Pharma Ambition
- A Clear Read on Lilly's Current M&A Logic
- When a Gray-Market Industry Gets a Seat at the Table
- Goodbye Autologous CAR-T: Why Taiwan's Cell-Therapy Bubble Also Needs to Break
- The Healthcare-Giant Spin-Off Wave
- Why Platform Biotechs Can Generate Five Times More Licensing Revenue
- Investors Should Pay Attention: Drug Delivery Is a Blue Ocean
- Do COPD Patients Finally Have Another New Drug Option?
- The Three AI Giants Battling Inside Medicine
